GlassScriptPhysician profile
Ryan M Barlotta
NPI 1710472568
$6,004.77
in general payments reported to CMS, 2019-2025
11 companies · $400 in 2025
The $400 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $15.40 · 2021: $355 · 2022: $2,802 · 2023: $1,762 · 2024: $307 · 2025: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,722 · Travel and Lodging: $748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,721.73 |
| Travel and Lodging | $747.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,489.46 | 2019-2025 | Ams 700, Spaceoar Vue System - 10ml |
| Coloplast Corp | $1,571.94 | 2021-2025 | Titan |
| Medtronic, INC. | $328.71 | 2021-2025 | Interstim |
| Urogen Pharma, INC. | $125.21 | 2023 | Jelmyto |
| Janssen Scientific Affairs, LLC | $122.33 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $117.94 | 2022-2023 | |
| Blue Earth Diagnostics | $114.69 | 2019 | |
| Laborie Medical Technologies Corp. | $55.65 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Endo Pharmaceuticals INC. | $30.52 | 2020-2022 | |
| Janssen Biotech, INC. | $25.19 | 2023 | Erleada |
| Procept Biorobotics Corporation | $10.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Barlotta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.